tiprankstipranks
Trending News
More News >
Immunome (IMNM)
NASDAQ:IMNM
US Market
Advertisement

Immunome (IMNM) Technical Analysis

Compare
317 Followers

Technical Sentiment

Overall Consensus
Neutral
7Bullish
6Neutral
9Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Immunome’s (IMNM) Moving Averages Convergence Divergence (MACD) indicator is 0.34, suggesting Immunome is a Buy.
Immunome’s (IMNM) 20-Day exponential moving average is 10.30, while Immunome’s (IMNM) share price is $9.87, making it a Sell.
Immunome’s (IMNM) 50-Day exponential moving average is 9.67, while Immunome’s (IMNM) share price is $9.87, making it a Buy.

Immunome (IMNM) Pivot Points

Aug 08, 2025, 03:08 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.64
9.94
10.20
10.50
10.76
11.06
11.32
Fibonacci
9.94
10.15
10.29
10.50
10.71
10.85
11.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunome (IMNM) Moving Averages

Aug 08, 2025, 03:08 PM
Period
Simple
Exponential
MA5
10.54Sell
10.41Sell
MA10
10.63Sell
10.50Sell
MA20
10.36Sell
10.30Sell
MA50
9.53Buy
9.67Buy
MA100
8.62Buy
9.45Buy
MA200
9.81Buy
10.42Sell
Immunome’s (IMNM) 10-Day exponential moving average is 10.50, while Immunome’s (IMNM) share price is $9.87, making it a Sell.
Immunome’s (IMNM) 100-Day exponential moving average is 9.45, while Immunome’s (IMNM) share price is $9.87, making it a Buy.
Immunome’s (IMNM) stock price is $9.87 and Immunome’s (IMNM) 50-day simple moving average is 9.53, creating a Buy signal.
Immunome’s (IMNM) stock price is $9.87 and Immunome’s (IMNM) 100-day simple moving average is 8.62, creating a Buy signal.
Immunome’s (IMNM) stock price is $9.87 and Immunome’s (IMNM) 200-day simple moving average is 9.81, creating a Buy signal.

Immunome (IMNM) Technical Indicators

Aug 08, 2025, 03:08 PM
Name
Value
Implied Action
RSI (14)
46.73
Neutral
STOCH (9,6)
24.83
Neutral
STOCHRSI (14)
26.40
Neutral
MACD (12,26)
0.34
Buy
ADX (14)
20.24
Neutral
Williams %R
-96.28
Buy
CCI (14)
-20.46
Neutral
ATR (14)
0.59
-
Ultimate Oscillator
43.45
Neutral
ROC
-6.71
Sell
Immunome’s (IMNM) Relative Strength Index (RSI) is 46.73, creating a Neutral signal.
Immunome’s (IMNM) Trend Strength Indicator (ADX) is 20.24, creating a Neutral signal.
Immunome’s (IMNM) Commodity Channel Index (CCI) is -20.46, creating a Neutral signal.
Immunome’s (IMNM) Price Rate of Change (ROC) is -6.71, creating a Sell signal.

FAQ

Is IMNM a Buy, Hold, or Sell?
Based on IMNM’s technical indicators, IMNM is a Hold.
    What is IMNM’s RSI (14)?
    IMNM’s RSI (14) is 46.73, which suggests IMNM is a Neutral.
      What is IMNM’s MACD?
      IMNM’s MACD is 0.34, which suggests IMNM is a Buy.
        What is IMNM’s 5-day moving average?
        IMNM’s 5-day moving average is 10.54, which suggests IMNM is a Sell.
          What is IMNM’s 20-day moving average?
          IMNM 20-day moving average is 10.36, which suggests IMNM is a Sell.
            What is IMNM’s 50-day moving average?
            IMNM’s 50-day moving average is 9.53, which suggests IMNM is a Buy.
              What is IMNM’s 200-day moving average?
              IMNM’s 200-day moving average is 9.81, which suggests IMNM is a Buy.
                What is IMNM’s Williams % R (14)?
                IMNM’s Williams % R (14) is -96.28, which suggests IMNM is a Buy.
                  What is IMNM’s CCI (14)?
                  IMNM’s CCI (14) is -20.46, which suggests IMNM is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis